3M's Ups and Downs: A Patient Investor's Guide

3Ms stock has seen a rollercoaster ride for investors, with a nearly seventy percent climb over three years, but also an eleven percent drop in five years and a fifteen percent fall from its fifty-two-week high. Despite this, adjusted earnings surged ten percent in 2025 and fourteen percent in the first quarter of 2026, with a solid two point one percent dividend yield attracting growth and income hunters. The companys spin-off of its healthcare unit into Solventum last year has helped address legal issues, and while the stocks volatility reflects the cyclical industrial world, patient investors can expect steady rewards as 3M settles lawsuits and continues to grow at a slower pace. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4c9ebeff16c2a950